Alopecia areata (AA) is characterized by common non-scarring alopecia due to autoimmune
disorders. To date, the specific pathogenesis underlying AA remains unknown. Thus, AA …

Alopecia areata (AA) is a chronic, multifactorial, polygenic, and heterogeneous disorder
affecting growing hair follicles in susceptible individuals, which results in a non-scarring and …

Background Janus kinase (JAK) inhibitors have shown encouraging results in the treatment
of alopecia areata (AA), an autoimmune form of hair loss, in small, uncontrolled studies and …

Background The mechanisms driving alopecia areata (AA) are still unclear, hindering
development of targeted therapeutics. Specific Th2 targeting with dupilumab in AA provides …

Background Patients with atopic dermatitis (AD) have systemic biomarker dysregulation that
differs by age group; however, the proteomic characteristics of these age-based changes …

Alopecia areata/AA is an autoimmune cause of nonscarring hair loss. The pathogenesis of
AA involves many immune axes, including Th1/Th2 pathways. Delgocitinib is a pan-Janus …

Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …

Background Alopecia areata (AA) is a common, acquired, and nonscarring type of hair loss
that affects people of every generation and is intractable in severe and relapsing cases …

Background Although alopecia areata (AA) greatly impacts patients' quality of life (QoL),
there is no adequate validation of AA‐targeted QoL surveys in clinical trials, hindering …

Introduction Alopecia areata (AA) is a non-scarring, hair loss disorder and a common
autoimmune-mediated disease with an estimated lifetime risk of about 2%. To date, the …